Patents by Inventor Iain Walters

Iain Walters has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20230330084
    Abstract: The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators, including their use for treating amyotrophic lateral sclerosis (ALS).
    Type: Application
    Filed: March 15, 2023
    Publication date: October 19, 2023
    Applicant: Corcept Therapeutics, Inc.
    Inventors: Hazel Hunt, Tony Johnson, Nicholas Ray, Iain Walters
  • OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20230167111
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: December 9, 2022
    Publication date: June 1, 2023
    Applicant: Corcept Therapeutics, Inc.
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet
  • Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
    Patent number: 11648245
    Abstract: The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators, including their use for treating amyotrophic lateral sclerosis (ALS).
    Type: Grant
    Filed: July 28, 2021
    Date of Patent: May 16, 2023
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Hazel Hunt, Tony Johnson, Nicholas Ray, Iain Walters
  • Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
    Patent number: 11576907
    Abstract: The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: January 12, 2021
    Date of Patent: February 14, 2023
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Hazel Hunt, Tony Johnson, Nicholas Ray, Iain Walters
  • Octahydro fused azadecalin glucocorticoid receptor modulators
    Patent number: 11560379
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: January 12, 2021
    Date of Patent: January 24, 2023
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet
  • Octahydro fused azadecalin glucocorticoid receptor modulators
    Patent number: 11370789
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: June 28, 2022
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet
  • Indole derivatives and their use as protein kinase inhibitors
    Patent number: 11208381
    Abstract: The present invention relates inter alia to a compound of formula (I) wherein R1, R2 and R3, are as defined in the specification and to compositions comprising the same and to the use of the compounds and to compositions of the compounds in treatment, for example in the treatment of fibrotic diseases or interstitial lung diseases, in particular idiopathic pulmonary fibrosis.
    Type: Grant
    Filed: June 1, 2020
    Date of Patent: December 28, 2021
    Assignee: RESPIVERT LIMITED
    Inventors: Iain Walters, Louise Birch, Stephen Paul Collingwood, Christopher Scott Stevenson
  • HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20210369701
    Abstract: The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators, including their use for treating amyotrophic lateral sclerosis (ALS).
    Type: Application
    Filed: July 28, 2021
    Publication date: December 2, 2021
    Inventors: Hazel Hunt, Tony Johnson, Nicholas Ray, Iain Walters
  • Pyrazolyl-ureas as kinase inhibitors
    Patent number: 11142515
    Abstract: There are provided compounds of formula (I) as defined in the specification which are p38 MAP kinase inhibitors for use as medicaments for the treatment inter alia of inflammatory diseases.
    Type: Grant
    Filed: March 27, 2019
    Date of Patent: October 12, 2021
    Assignee: Respivert Limited
    Inventors: Alistair Ian Longshaw, Euan Alexander Fraser Fordyce, Stuart Thomas Onions, John King-Underwood, Jennifer Diane Venable, Iain Walters
  • Indolinones compounds and their use in the treatment of fibrotic diseases
    Patent number: 11046672
    Abstract: The present invention relates inter alia to a compound of formula (I) Wherein R1, R2, R3 and Z are as defined in the specification and to compositions comprising the same and to the use of the compounds and to compositions of the compounds in treatment, for example in the treatment of fibrotic diseases or interstitial lung diseases, in particular idiopathic pulmonary fibrosis.
    Type: Grant
    Filed: December 23, 2016
    Date of Patent: June 29, 2021
    Assignee: RespiVert Limited
    Inventors: Iain Walters, Louise Birch, Joseph Hill-Cousins, Stephen Paul Collingwood, Christopher Scott Stevenson
  • HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20210169872
    Abstract: The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: January 12, 2021
    Publication date: June 10, 2021
    Inventors: Hazel Hunt, Tony Johnson, Nicholas Ray, Iain Walters
  • OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20210139478
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: January 12, 2021
    Publication date: May 13, 2021
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet
  • INDOLE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
    Publication number: 20210114982
    Abstract: The present invention relates inter alia to a compound of formula (I) wherein R1, R2 and R3, are as defined in the specification and to compositions comprising the same and to the use of the compounds and to compositions of the compounds in treatment, for example in the treatment of fibrotic diseases or interstitial lung diseases, in particular idiopathic pulmonary fibrosis.
    Type: Application
    Filed: June 1, 2020
    Publication date: April 22, 2021
    Inventors: Iain Walters, Louise Birch, Stephen Paul Collingwood, Christopher Scott Stevenson
  • Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
    Patent number: 10973813
    Abstract: The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: September 13, 2019
    Date of Patent: April 13, 2021
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Hazel Hunt, Tony Johnson, Nicholas Ray, Iain Walters
  • OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20200361935
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: August 4, 2020
    Publication date: November 19, 2020
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet
  • Octahydro fused azadecalin glucocorticoid receptor modulators
    Patent number: 10787449
    Abstract: The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: September 29, 2020
    Assignee: CORCEPT THERAPEUTICS, INC.
    Inventors: Hazel Hunt, Iain Walters, Benoit Gourdet
  • Indole derivatives and their use as protein kinase inhibitors
    Patent number: 10669235
    Abstract: The present invention relates inter alia to a compound of formula (I) wherein R1, R2 and R3, are as defined in the specification and to compositions comprising the same and to the use of the compounds and to compositions of the compounds in treatment, for example in the treatment of fibrotic diseases or interstitial lung diseases, in particular idiopathic pulmonary fibrosis.
    Type: Grant
    Filed: March 8, 2017
    Date of Patent: June 2, 2020
    Assignee: RESPIVERT LIMITED
    Inventors: Iain Walters, Louise Birch, Stephen Paul Collingwood, Christopher Scott Stevenson
  • HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20200009131
    Abstract: The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: September 13, 2019
    Publication date: January 9, 2020
    Inventors: Hazel Hunt, Tony Johnson, Nicholas Ray, Iain Walters
  • INDOLINONES COMPOUNDS AND THEIR USE IN THE TREATMENT OF FIBROTIC DISEASES
    Publication number: 20190337929
    Abstract: The present invention relates inter alia to a compound of formula (I) Wherein R1, R2, R3 and Z are as defined in the specification and to compositions comprising the same and to the use of the compounds and to compositions of the compounds in treatment, for example in the treatment of fibrotic diseases or interstitial lung diseases, in particular idiopathic pulmonary fibrosis.
    Type: Application
    Filed: December 23, 2016
    Publication date: November 7, 2019
    Inventors: Iain Walters, Louise Birch, Joseph Hill-Cousins, Stephen Paul Collingwood, Christopher Scott Stevenson
  • Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
    Patent number: 10456392
    Abstract: The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: October 29, 2019
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Hazel Hunt, Tony Johnson, Nicholas Ray, Iain Walters